Lung Cancer Trials
CALGB-140503 - A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (≤ 2 cm) Peripheral Non- Small Cell Lung Cancer.
E4512 (ECOG-ACRIN) - A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein.
A081105 (ALLIANCE) -Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC).
A151216 – ALCHEMIST (ALLIANCE) - Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST).